
Unibros Pharma Private Limited
About Unibros Pharma Private Limited
Data last updated:
Unibros Pharma Private Limited was a private limited company based in Agra, Uttar Pradesh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 18 December 2012.
The company was registered with the Registrar of Companies (ROC), Kanpur, under CIN U85191UP2012PTC054231. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Mahesh Chaudhary and Priyanka Chaudhary.
Its last annual general meeting (AGM) was held on 12 October 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at 3 State Bank Colony Khandari, Agra, Uttar Pradesh, India – 282005.
As per the financials filed for FY 2020, the company reported a revenue of ₹8.75 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹3.71 Lakh (net margin -42.4%) and EBITDA of -₹3.69 Lakh (EBITDA margin -42.2%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 11% over five years.
Company details
Contact details
Unibros Pharma Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3 State Bank Colony Khandari, Agra, Uttar Pradesh, India – 282005
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Unibros Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unibros Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Unibros Pharma Private Limited, buy the company report.
Financials of Unibros Pharma Private Limited
FY 2020 filings availableUnibros Pharma Private Limited reported revenue of ₹8.75 Lakh (up 9% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 11%. EBITDA fell 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -42.2% | ||||
| Net Profit Margin | -42.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unibros Pharma Private Limited, buy the company report.
Board of directors of Unibros Pharma Private Limited
Unibros Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahesh Chaudhary | Director | 15 Jul 2013 | 13 Years 4 Months | As last reported |
| Priyanka Chaudhary | Director | 18 Dec 2012 | 13 Years 11 Months | As last reported |
| Nepal Singh | Director | 18 Dec 2012 | 13 Years 11 Months | As last reported |
Peer comparison
Unibros Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| QTS Digital Advanced Services Private Limited | ₹8.75 Lakh (FY 2025) | -13.0% | Bareilly, Uttar Pradesh, India | |||
| Padma Sales Private Limited | ₹8.75 Lakh (FY 2024) | 4.0% | Kolkata, West Bengal, India | |||
| Groove Pharmaceuticals Private Limited | ₹8.75 Lakh (FY 2024) | -27.0% | Mandir, Chembur (W), Maharashtra, India | |||
| Kripa Sleep Systems Private Limited | ₹8.75 Lakh (FY 2024) | -53.0% | Bangalore, Karnataka, India | |||
| Harmed Pharmaceutical Private Limited | ₹8.75 Lakh (FY 2024) | -63.0% | Patna, Bihar, India | |||
| Unibros Pharma Private Limitedthis company | ₹8.75 Lakh (FY 2020) | -₹3.71 Lakh | -42.4% | 9.0% | Agra, Uttar Pradesh, India | |
| Ultimate Infrabuild Private Limited | ₹8.75 Lakh (FY 2024) | 9.0% | Kolkata, West Bengal, India | |||
| Av Giruz Hospitality Private Limited | ₹8.74 Lakh (FY 2020) | Gurgaon, Haryana, India | ||||
| Vardhman Suppliers Private Limited | ₹8.74 Lakh (FY 2025) | -97.0% | Jaipur, Rajasthan, India | |||
| Atmiya Decors Private Limited | ₹8.74 Lakh (FY 2021) | Vallabh Vidyanagar, Gujarat, India | ||||
| Goldcoin Health Foods Limited | ₹8.74 Lakh (FY 2025) | 94.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Unibros Pharma Private Limited, buy the company report.
Auditor
Unibros Pharma Private Limited is audited by AMBIKA PRASAD SHARMA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMBIKA PRASAD SHARMA & CO. | FY 2017 | 007127C |
Shareholding
The shareholding of Unibros Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Unibros Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unibros Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unibros Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unibros Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Unibros Pharma Private Limited, buy the company report.
Recent activity
Unibros Pharma Private Limited has 3 board changes on record since 2012: 3 appointments. The latest: Mahesh Chaudhary was appointed as Director on 15 Jul 2013.
Frequently asked questions
Unibros Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Unibros Pharma was a private limited company based in Agra, Uttar Pradesh, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 18 December 2012 and is registered under CIN U85191UP2012PTC054231. The company has been struck off by the Registrar of Companies and is no longer operational.
Unibros Pharma had 3 directors:
- Mahesh Chaudhary - Director
- Priyanka Chaudhary - Director
- Nepal Singh - Director
The CIN (Corporate Identification Number) of Unibros Pharma is U85191UP2012PTC054231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Unibros Pharma is at 3 State Bank Colony Khandari, Agra, Uttar Pradesh, India – 282005.
Unibros Pharma was incorporated on 18 December 2012. It is registered with the Registrar of Companies, Kanpur.
The latest financial statements of Unibros Pharma on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 12 October 2020. Year-wise statements from 2015 are in the company report.
No. Unibros Pharma has 1 GST registration on record and it is cancelled or inactive.
Unibros Pharma operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Unibros Pharma by revenue are QTS Digital Advanced Services Private Limited, Padma Sales Private Limited, Groove Pharmaceuticals Private Limited, Kripa Sleep Systems Private Limited, Harmed Pharmaceutical Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mahesh Chaudhary was appointed as Director on 15 Jul 2013. Nepal Singh was appointed as Director on 18 Dec 2012. Priyanka Chaudhary was appointed as Director on 18 Dec 2012.

